This study is testing a new way to manage gout (a type of arthritis caused by too much uric acid in the blood) using pharmacists. It compares regular care to a program where pharmacists provide telehealth (virtual) visits to help Veterans adjust their gout medications, like allopurinol or febuxostat. The goal is to see if this pharmacist-led approach can reduce gout flares and help more Veterans reach their target uric acid levels. You might be able to join if you are a US Veteran over 18 with diagnosed gout, high uric acid levels, and have had at least one gout flare in the last six months. The study is currently recruiting, but its exact status is unclear.

Study design

This study is an interventional study with a planned enrollment of 310 US Veterans. It compares a pharmacist-led telehealth intervention to usual care.

What's involved

If you participate, you will receive regular telehealth visits with a pharmacist during the dose escalation phase of your gout treatment. Your individual participation will last up to two years.

Compensation

Not stated in the trial record.

Follow-up

The study measures flare occurrence during year two and serum urate at goal at the end of year one.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.